"The Dubai thing seemed to involve a risk of introducing a...

"The Dubai thing seemed to involve a risk of introducing a dangerous and counter-productive 'snake-oil' flavour to Cvac, to me, given that any reports would not be statisticaly valid and now we learn the sums on it being profitable were 'immature' and/or thwarted by production/export hurdles and that provision of other PRR services would not be sufficient compensation."

Good onya misterS,

I had those exact concerns and tried get some clarity regarding Dubai from MR. It seemed to me that any anecdotal hyping from Dubai would be frowned upon by the FDA at a crucial stage with phase 3 trials presumably well under way. Anyway, did not get any answers at all, understandable considering what has transpired.

And yes of course, Cvac trials and results have always been the main game. Management have only reassured me in my investment decision with the recent announcements.

All the best,meg